Table 3.

The effect of invigorating-spleen and anticancer prescription on tumor inhibition rate of mice

Group	Tumor weight (g; mean ± SD)	Tumor inhibition rate (%)
Control group	1.38 ± 0.12	/
Low-dose group of ISAP	1.22 ± 0.03	0.12 ± 0.02
Medium-dose group of ISAP	1.07 ± 0.34a	0.31 ± 0.08b
High-dose group of ISAP	0.9 ± 0.08a	0.34 ± 0.05b
Capecitabine group	0.53 ± 0.13a	0.59 ± 0.03b

^a P < 0.05 compared to the control group.

^b P < 0.05 compared to the low-dose group of invigorating-spleen and anticancer prescription.

ISAP: Invigorating-spleen and anticancer prescription.